MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Cash Flow
NASDAQ:MREO - Nasdaq - US5894921072 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | -34.65M | -44.47M | 19.58M | -213.41M | |||
| Depreciation Amortization | 1.09M | 1.06M | 895.70K | 882.80K | 2.05M | |||
| Change In Working Capital | -43.62M | -31.06M | 359.70K | 1.35M | 9.01M | |||
| Interest Paid | 21.00K | 884.00K | 0.00 | 0.00 | 3.72M | |||
| Taxes Paid | 0.00 | 1.34M | 1.88M | -3.88M | -13.38M | |||
| Other non cash items | 9.70M | 8.87M | -4.62M | -29.02M | 166.02M | |||
| OPERATING CASH FLOW | -32.83M | -21.13M | -47.83M | -7.20M | -36.34M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -699.00K | -419.00K | -12.30K | -735.70K | -20.50K | |||
| Other Investing Activity | N/A | 0.00 | 1.86M | 156.80K | 1.94M | |||
| INVESTING CASH FLOW | -699.00K | -419.00K | 1.84M | -578.90K | 1.92M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -3.19M | -1.15M | -951.50K | 28.83M | |||
| Stock Issued/Repurchased | 47.00M | 11.61M | 0.00 | 108.05M | 25.82M | |||
| Other Financing Activity | -853.00K | -444.00K | 188.50K | -321.80K | -10.11M | |||
| FINANCING CASH FLOW | 46.15M | 7.97M | -965.90K | 106.78M | 44.54M | |||
| Exchange Rate Effect | -233.00K | 2.82M | 178.60K | -1.60M | -986.00K | |||
| CHANGE IN CASH | 12.38M | -10.76M | -46.77M | 97.39M | 9.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.83M | -21.13M | -47.83M | -7.20M | -36.34M | |||
| Capital Expenditure | -699.00K | -419.00K | -12.30K | -735.70K | -20.50K | |||
| FREE CASH FLOW | -33.53M | -21.55M | -47.84M | -7.94M | -36.36M | |||
All data in USD